TECHNOLOGIES

AbAccel®
Antibody Optimization

AbAccel® is an innovative platform focused on developability that enables multi-factor antibody optimization in a single process.
 

Existing antibody molecules are converted in proprietary AbAccel® libraries and screened for variants with optimized affinities and biophysical properties

Proprietary AbAccel® libraries are cloned for existing lead candidates and screened for variants with optimized affinities and biophysical properties. AbAccel® has identified optimized antibody candidates that demonstrated a more than 100-fold improved affinity, while preserving other properties such as species cross-reactivity, specificity and stability. Lead optimization with AbAccel® is based on a proprietary algorithm. HCDR3 regions of lead candidates are identified and transferred to a compatible VH/VL framework pair with proven performance for GMP production.

TECHNOLOGY DIAGRAM

Affinity Maturation & Optimization Principle

TECHNOLOGY DIAGRAM
LET’S DISCOVER OUR OTHER TECHNOLOGIES


AbSieve®
Antibody Selection

Technologies


Proprietary
Libraries

Technologies

Microfluidics

Technologies


Rabbit Mass
Humanization

Technologies

Single Copy
Integration Site
Technology

Technologies

Classical Antibody
Discovery
Technologies

Technologies

Our Services

Antibody
Discovery

Services

Antibody
Optimization

Services

Our Unique Platforms

Proprietary
Libraries

Technologies

Rabbit Mass
Humanization

Technologies

AbSieve®
Antibody
Selection

Technologies

AbAccel®
Antibody
Optimization

Technologies